IL1B and Alzheimer disease: This effectively reduces the microbial load and the resulting inflammatory mediators, such as IL-1β and prostaglandin E2 (PGE2) in periodontal tissues, thereby decreasing systemic inflammation and subsequently reducing the risk or severity of AD [27].